Our Services: Public and Private Payer Submissions
DBR Canada Inc. staff is experienced planning, preparing, and managing Common Drug Review (CDR) submissions for both new chemical entities and new combination drugs. Our experience extends to the complete CDR process including;
- Filing of submissions with participating Federal, Provincial, and Territorial plans.
- Responding, on behalf of manufacturers, to CDR clinical and economic reviewer comments
Planning, preparing, and management of Private Payer reimbursement submissions, including paper based and electronic submissions (CD) for new chemical entities and new combination drugs.
Our expertise includes managing the reimbursement process and filing reimbursement submissions for line extensions with Federal, Provincial, and Private Payers.
Our staff is highly skilled and has an in-depth knowledge of Canadian public and private payers’ decision making processes and submission needs and requirements.
|
